The Food and Drug Administration (FDA) is evaluating whether it should take some form of regulatory action after receiving reports of a condition called drug reaction with eosinophilia and systemic symptoms, or DRESS, in patients taking a class of antidepressants called selective serotonin reuptake inhibitors, or SSRIs. DRESS syndrome is caused by exposure to certain medications and may result in a rash, fever, inflammation of internal organs, lymphadenopathy, and characteristic hematologic abnormalities such as eosinophilia, thrombocytopenia, and atypical lymphocytosis. SSRIs are used to treat depression, seasonal affective disorder (SAD), general anxiety disorder, obsessive-compulsive disorder, and in some cases smoking cessation, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.